Lexicon Pharmaceuticals (LXRX) Interest Coverage Ratio Growth (1y) (2011 - 2023)
Lexicon Pharmaceuticals (LXRX) Interest Coverage Ratio Growth (1y) (2011 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
18.06% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-303.06% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
67.94% |
| 10 |
Lexicon Pharmaceuticals |
804.48 Mn |
633.82 Mn |
20.99 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2023 |
52.38% |
| Jun 30, 2023 |
33.90% |
| Mar 31, 2023 |
91.95% |
| Dec 31, 2022 |
68.03% |
| Sep 30, 2022 |
80.09% |
| Jun 30, 2022 |
67.86% |
| Mar 31, 2022 |
-70.33% |
| Dec 31, 2021 |
-95.72% |
| Sep 30, 2021 |
-737.98% |
| Jun 30, 2021 |
-743.33% |
| Mar 31, 2021 |
-925.45% |
| Dec 31, 2020 |
-382.31% |
| Sep 30, 2020 |
-51.25% |
| Jun 30, 2020 |
-250.88% |
| Mar 31, 2020 |
-256.45% |
| Dec 31, 2019 |
-284.30% |
| Sep 30, 2019 |
1,089.00% |
| Jun 30, 2019 |
38.47% |
| Mar 31, 2019 |
53.72% |
| Dec 31, 2018 |
82.36% |
